Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Diabetes Treatment and Management, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer, and Genetic Associations and Epidemiology.
Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis
Subclassification of obesity for precision prediction of cardiometabolic diseases
Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study
BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study
Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes
Routine measurement of cardiometabolic disease risk factors in primary care in England before, during, and after the COVID-19 pandemic: A population-based cohort study
Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes
Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models
Identification of biomarkers for glycaemic deterioration in type 2 diabetes
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review
The Impact of the COVID-19 Pandemic on the Measurement of Routine Cardiometabolic Disease Risk Factors in Primary Care in the Population of England (57 Million People)
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study
Elevated circulating follistatin associates with an increased risk of type 2 diabetes
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY Study
Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-Hour OGTT: An IMI DIRECT Study
Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a <i>Diabetes Care</i> Editors’ Expert Forum
Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts
First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes
Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference
Genetic Variants in <i>CPA6</i> and <i>PRPF31</i> Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes
A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants
A common missense variant of LILRB5 is associated with statin intolerance and myalgia
Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin
Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta‐Analysis
Gene-Environment and Gene-Treatment Interactions in Type 2 Diabetes
The <i>CTRB1/2</i> Locus Affects Diabetes Susceptibility and Treatment via the Incretin Pathway